← Eichor
Study identifier: NCT05475600 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU

Condition: Adapted Physical Activity · Hematological Malignancies · Anxiety  ·  Sponsor: Centre Hospitalier Régional Metz-Thionville

PhaseNA
Planned participants90
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Adapted Physical Activity (APA) is accepted as an effective, recommended and beneficial supportive care for the health of people with cancer during the different phases of the disease. The objective of the project is to analyse the effect of APA programs (Classic, Exergaming and Relaxation) on the state anxiety of people with severe blood diseases admitted to Intensive Care Unit (ICU). Anxiety is a major affect in this context. The interest of the practice of APA for this public is to reduce the level of state anxiety and to limit the decline of functional capacities. The main objective of this work is to identify whether specific and/or complementary effects result from the use of biofeedback and/or Exergaming.

This description comes directly from the study's public registry record.

Talk to the study team

Arpiné EL NAR, PhD  ·  0033387557766  ·  projet-recherche-clinique@chr-metz-thionville.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHR Metz-Thionville/Hopital de MercyMetz, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05475600